Search

Your search keyword '"François Xavier Lescure"' showing total 219 results

Search Constraints

Start Over You searched for: Author "François Xavier Lescure" Remove constraint Author: "François Xavier Lescure"
219 results on '"François Xavier Lescure"'

Search Results

1. Antimicrobial prescribing in French nursing homes and interventions for antimicrobial stewardship: a qualitative study

2. Monkeypox clade IIb in France in 2023–2024

3. Long Covid: a global health issue – a prospective, cohort study set in four continents

4. Implementation of a Clinical Decision Support System for Antimicrobial Prescribing in Sub-Saharan Africa: Multisectoral Qualitative Study

5. Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients

6. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

7. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

8. Mpox: The alarm went off. Have we gone back to sleep?

9. Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study

10. Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study

11. Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

12. Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19

13. Impact of ICU transfers on the mortality rate of patients with COVID-19: insights from comprehensive national database in France

14. Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study

15. Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance

16. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

17. Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France

18. Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections

19. Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study

20. Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function

21. Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?

23. Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments

24. Cholangitis in three critically ill patients after a severe CoVID-19 infection

25. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults

26. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

27. Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV.

28. Correction: Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV.

29. Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools

30. Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease

32. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

33. Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study.

34. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

35. Characteristics, management, and outcomes of patients with infectious encephalitis requiring intensive care: A prospective multicentre observational study

36. COVID-19 : les thérapeutiques

37. Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients

39. Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial

40. Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France

41. Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.

42. A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak

43. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study

44. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

45. Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France

46. Association between renin–angiotensin–aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment

47. Clinical and virological data of the first cases of COVID-19 in Europe: a case series

48. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications

49. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists

50. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

Catalog

Books, media, physical & digital resources